Key result
Two-dimensional speckle-tracking echocardiography detected early radiotherapy-related cardiac systolic dysfunction, with decreases in left ventricular global longitudinal strain linearly correlating with mean heart dose.
Why the study?
Radiotherapy-induced cardiac toxicity affects long-term cancer survival, prompting the evaluation of two-dimensional speckle-tracking echocardiography for early cancer therapy-related cardiac dysfunction and risk factor assessment.
Does two-dimensional speckle-tracking echocardiography (2D-STE) detect early cancer therapy-related cardiac dysfunction in patients receiving radiotherapy for thoracic tumors?
Cohort (n=40)
No
Does two-dimensional speckle-tracking echocardiography (2D-STE) detect early cancer therapy-related cardiac dysfunction in patients receiving radiotherapy for thoracic tumors?
Answers are grounded in this paper and cite their sources.
2D-STE can detect radiotherapy-related early cardiac systolic dysfunction more sensitively than conventional echocardiography, with mean heart dose (MHD) correlating with left ventricular systolic function decline.
Background: The cardiac toxicity of radiotherapy (RT) can affect cancer survival rates over the long term. The purpose of this study was to evaluate the value of two-dimensional speckle-tracking echocardiography (2D-STE) in early cancer therapy–related cardiac dysfunction (CTRCD), and to evaluate the risk factors of CTRCD and their effects on survival. Methods: We ultimately enrolled 40 patients who received RT for thoracic tumors. For each patient, 2D-STE was completed before, during, and after RT and in the follow up. We analyzed the sensitivity of 2D-STE in predicting CTRCD and the relationship between RT parameters and cardiac systolic function decline. Results: Left ventricle global longitudinal strain (LVGLS), LVGLS of the endocardium (LVGLS-Endo), LVGLS of the epicardium (LVGLS-Epi), and free-wall longitudinal strain (FWLS) decreased mid- and post-treatment compared with pre-treatment, whereas traditional parameters such as left ventricular ejection fraction (LVEF), cardiac Tei index (Tei), and peak systolic velocity of the free wall of the tricuspid annulus (s’) did not show any changes. The decreases in the LVGLS and LVGLS-Endo values between post- and pre-treatment and the ratios of the decreases to the baseline values were linearly correlated with mean heart dose (MHD) (all P values < 0.05). The decreases in the LVGLS-Epi values between post- and pre-treatment and the ratios of the decreases to the baseline values were linearly correlated with the percentage of heart volume exposed to 5 Gy or more (V5) ( P values < 0.05). The decrease in FWLS and the ratio of the decrease to the baseline value were linearly related to MHD and patient age (all P values < 0.05). Endpoint events occurred more frequently in the right side of the heart than in the left side. Patients over 56.5 years of age had a greater probability of developing right-heart endpoint events. The same was true for patients with MHD over 2020 cGy in both the left and right sides of the heart. Conclusions: 2D-STE could detect damages to the heart earlier and more sensitively than conventional echocardiography. MHD is an important prognostic parameter for LV systolic function, and V5 may also be an important prognostic parameter. MHD and age are important prognostic parameters for right ventricle systolic function.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) conducted a cohort in Thoracic tumors (n=40). Radiotherapy vs. Pre-treatment baseline was evaluated on Correlation between decrease in LVGLS/LVGLS-Endo from baseline and mean heart dose (p=<0.05). Two-dimensional speckle-tracking echocardiography detected early radiotherapy-related cardiac systolic dysfunction, with decreases in left ventricular global longitudinal strain linearly correlating with mean heart dose.
Synapse has enriched 10 related papers. Consider them for comparative context: